ArticleFrontiers in digital health2025
Enhancing heart disease prediction with stacked ensemble and MCDM-based ranking: an optimized RST-ML approach.
Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Development and Interpretability Analysis of a Stacking Ensemble Model for Early Prediction of Nutritional Risk in Intensive Care Unit Patients: Retrospective Cohort Study.JMIR medical informatics · 2026Article
- Leakage-Safe Precision-Aware Dual-Branch FT-Transformer for Population-Scale Heart Disease Risk Prediction.Sensors (Basel, Switzerland) · 2026Article
- Heart disease prediction using rough neutrosophic sets and dual-attention neural networks: RNS-OptiDANet.Frontiers in artificial intelligence · 2026Article
- Machine learning techniques for improved prediction of cardiovascular diseases using integrated healthcare data.Frontiers in artificial intelligence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cardiovascular disease (CVD) is a leading global cause of death, necessitating the development of accurate diagnostic models. This study presents an Optimized Rough Set Theory-Machine Learning (RST-ML) framework that integrates Multi-Criteria Decision-Making (MCDM) for effective heart disease (HD) prediction. By utilizing RST for feature selection, the framework minimizes dimensionality while retaining essential information. Methods: The framework employs RST to select relevant features, followed by the integration of nine ML classifiers into five stacked ensemble models through correlation analysis to enhance predictive accuracy and reduce overfitting. The Technique for Order of Preference by Similarity to Ideal Solution (TOPSIS) ranks the models, with weights assigned using the Mean Rank Error Correction (MEREC) method. Hyperparameter tuning for the top model, Stack-4, was conducted using GridSearchCV, identifying XGBoost (XG) as the most effective classifier. To assess scalability and generalization, the framework was evaluated using additional datasets, including chronic kidney disease (CKD), obesity levels, and breast cancer. Explainable AI (XAI) techniques were also applied to clarify feature importance and decision-making processes. Results: Stack-4 emerged as the highest-performing model, with XGBoost achieving the best predictive accuracy. The application of XAI techniques provided insights into the model's decision-making, highlighting key features influencing predictions. Discussion: The findings demonstrate the effectiveness of the RST-ML framework in improving HD prediction accuracy. The successful application to diverse datasets indicates strong scalability and generalization potential, making the framework a robust and scalable solution for timely diagnosis across various health conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.